| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.05 | 0.4 |